Pan-European comparative genomics project to develop software suite for gene regulation analysis

NewsGuard 100/100 Score

Today, CLC bio announced to be heading a pan-European comparative genomics project, COGANGS (Comparative Genomics and Next Generation Sequencing), to develop a software suite, where up to one thousand genomes, can be used as knowledge input in gene regulation analysis.

“The integration of this software suite with our ExPlain data analysis solution and our TRANSFAC database will strengthen our position within the realm of Next Generation Sequencing. It will be a significant advance for understanding gene regulation, to the benefit of our existing and future customers.”

The project is sponsored by the European Union with 1.6 Million Euro, and besides CLC bio, the project involves, BIOBASE (Germany), deCODE genetics (Iceland), Alfréd Rényi Institute of Mathematics (Hungary), BioRainbow (Russia), and the University of Oxford (United Kingdom).

Director of Bioinformatics at deCODE Genetics, Gísli Másson, states, "It's highly interesting for us to participate in this project, as we can potentially unlock a lot of information in the vast collection of human DNA samples we already have, once this project enables us to do large-scale comparative genomics analyses. We will apply both the initial prototype and the final software package for the analysis of regions that have been identified to have strong disease associations in the human genome."

Chief Operating Officer at BIOBASE, Dr. Frank Schacherer, continues, "The integration of this software suite with our ExPlain data analysis solution and our TRANSFAC database will strengthen our position within the realm of Next Generation Sequencing. It will be a significant advance for understanding gene regulation, to the benefit of our existing and future customers."

The COGANGS project will develop a software suite, where a large number of genomes can be used as knowledge input in gene regulation analysis, like analysis of which factors influence gene regulation, how much impact they have on gene regulation, how they can be identified in the genome of interest, how different gene regulation factors influence each other, and how they work in combination. Such software will be able to provide completely new knowledge, and will thus have tremendous value to life science researchers globally.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness